Omalizumab in chronic urticaria: A comprehensive review

Journal Title: Türkderm - Deri Hastalıkları ve Frengi Arşivi - Year 2018, Vol 52, Issue 4

Abstract

Omalizumab is a humanized monoclonal anti-immunoglobulin E which is originally developed for the treatment of allergic respiratory disorders, but has been approved for the treatment of antihistamine-resistant chronic spontaneous urticaria in 2014. It has become a game changer in the treatment of all subtypes of chronic urticaria (CU) even though it has not been yet approved for inducible urticarias. It is a safe drug with minor adverse events reported in the clinical trials as well as real life studies. The main questions that remain to be answered regarding its use for CU are the duration of treatment, how to cease the treatment and safety of long-term use. Available information about these questions are tried to be provided in this review.

Authors and Affiliations

Emek Kocatürk Göncü, Kübra Kızıltaç, Tabi Leslie

Keywords

Related Articles

Evaluation of the use of complementary and alternative therapy in patients with psoriasis and acne vulgaris

Background and Design: The aim of this study was to explore the use of complementary and alternative medicine (CAM) therapy in patients with acne vulgaris (AV) and psoriasis and their attitudes towards CAM. Materials an...

Prognostic Value of the mRNA Expression of Members of the Toll-like Receptor Family in Clear Cell Renal Cell Carcinoma

Objective: The aim of this study was to examine TLRs expression in tumoral and non-tumoral kidney tissue in patients with clear cell renal cell carcinoma (ccRCC) and to evaluate the prognostic significance of TLRs expres...

Use of the ELISA (Em2-Em18) and Western Blotting Methods on Diagnosis of Alveolar Echinococcosis

Objective: Alveolar echinococcosis (AE) is one of the most lethal parasitic zoonoses in the Northern Hemisphere, and early serological detection is important to start treatment and to improve survival. A total of 50 sera...

Comparison of Robotic and Laparoscopic Partial Nephrectomy in Robotic Surgery Era

Objective: To compare the results of robotic partial nephrectomy (RPN) and laparoscopic partial nephrectomy (LPN) operations and to determine whether they have any superiority to each other in terms of oncological and fu...

Download PDF file
  • EP ID EP427145
  • DOI 10.4274/turkderm.26987
  • Views 132
  • Downloads 0

How To Cite

Emek Kocatürk Göncü, Kübra Kızıltaç, Tabi Leslie (2018). Omalizumab in chronic urticaria: A comprehensive review. Türkderm - Deri Hastalıkları ve Frengi Arşivi, 52(4), 112-119. https://europub.co.uk/articles/-A-427145